Editorial: For osteoporosis, are two antiresorptive drugs better than one?

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 3, 2002, Pages 983-984

  Ettinger, Bruce ^a   Bilezikian, John P ^b  

^a DIVISION OF RESEARCH   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; RALOXIFENE;

BONE DENSITY; BONE MINERALIZATION; BONE TURNOVER; CLINICAL TRIAL; DRUG COST; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; FRACTURE; HUMAN; INCIDENCE; MONOTHERAPY; OSTEOLYSIS; OSTEOPOROSIS; PRACTICE GUIDELINE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; DRUG COMBINATION; NOTE;

ALENDRONATE; DRUG THERAPY, COMBINATION; HUMANS; OSTEOPOROSIS; RALOXIFENE;

EID: 0036962096     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.3.983     Document Type: Editorial

References (8)

1. Johnell O, Scheele WH, Lu Y, Reginster J-Y, Need AG, Seeman E 2002 Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87:985-992
2. Bone HG, Greenspan SL, McKeever C, Bell N, Davidson M, Downs RW, Ernkey R, Meunier PJ, Miller SS, Mulloy AL, Recker RR, Weiss SR, Heyden N, Musliner T, Suryawanshi S, Yates AJ, Lombardi A 2000 Alendronate and estrogen effects in postmenopausal women with low bone density. J Clin Endocrinol Metab 85:720-726
3. Harris S, Eriksen EF, Davidson M, Ettinger MP, Moffett Jr AH Jr, Baylink DJ, Crusan CE, Chines AA 2001 Effect of combined risedronate and hormone replacement therapy on bone mineral density in postmenopausal women. J Clin Endocrinol Metab 86:1890-1897
4. Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ 2000 Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27:687-694
5. Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ 2001 Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100:1475-1480
6. Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB 2001 Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28:524-531
7. Roschger P, Fratzl P, Eschberger J, Klaushofer K 1998 Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 23:319-326
8. Roschger P, Grabner BM, Messmer P, Dempster DW, Cosman F, Nieves J, Lindsay R, Bilezikian JP, Kurland ES, Shane E, Fratzl P, Klaushofer K 2001 Influence of intermittent PTH on mineral distribution in the human ilium: a paired biopsy study before and after treatment (Abstract). J Bone Miner Res 16(Suppl 1):S179